SELE and metabolic dysfunction-associated steatotic liver disease: Hepatic E‐selectin mRNA expression increased with NAFLD severity from 7.05 ± 0.22 (NAS ≤ 2), to 7.12 ± 0.26 (NAS 3‐4) and to 7.24 ± 0.23 (NAS ≥ 5) (P for trend = .02), whereas an opposite trend was observed for hepatic VCAM mRNA expression (7.92 ± 0.21 [NAS ≤ 2], 7.77 ± 0.28 [NAS 3‐4] and 7.80 ± 0.21 [NAS ≥ 5], P for trend = .09).